文献速递妇科

高风险早期子宫内膜癌的淋巴结评估:比较前哨淋巴结算法与前哨淋巴结联合选择性淋巴结清扫的多机构回顾性分析

Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
PubMed 文献 · Gynecol Oncol · 2018-06-07

本研究多机构回顾性分析171例高风险特征子宫内膜癌患者,66例采用前哨淋巴结算法(SLN-A),105例采用前哨淋巴结联合选择性淋巴结清扫(S-LND)。5年无病生存率比较无显著差异(HR 0.82;95%CI 0.53-1.28;p=0.390)。SLN-A策略似乎未损害高复发风险患者的预后。

要点

  • 多机构回顾性分析纳入171例高风险早期子宫内膜癌手术分期患者。
  • SLN-A组66例与S-LND组105例的5年无病生存无显著差异(HR 0.82;95%CI 0.53-1.28;p=0.390)。
  • SLN策略似乎未损害高复发风险子宫内膜癌患者的预后。

核心结论

  • 在高风险组子宫内膜癌女性中,SLN-A策略与S-LND相比5年无病生存无差异(HR 0.82;95%CI 0.53-1.28;p=0.390)。
  • SLN策略似乎未损害复发风险较高患者的预后。

研究设计与样本

  • 多机构合作数据库的回顾性分析,纳入具有高风险特征并接受初次手术分期的子宫内膜癌女性171例。
  • SLN-A组66例,S-LND组105例。

主要发现

  • 共171例女性,SLN-A组66例,S-LND组105例。
  • 盆腔淋巴结清扫在115例(67.2%)中施行,S-LND组中主动脉淋巴结清扫在54/105例(51%)中施行。
  • 5年无病生存比较:SLN-A组 vs S-LND组 HR 0.82(95%CI 0.53-1.28;p=0.390),无显著差异。

关键数值与推荐

  • 5年无病生存(DFS):SLN-A组 vs S-LND组 HR 0.82(95%CI 0.53-1.28;p=0.390)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the impact of the sentinel lymph node mapping algorithm (SLN-A) on the staging in high-risk endometrial cancer (EC) compared to SLN plus selective lymphadenectomy (S-LND). METHODS: We retrospectively analyzed the database from a multicenter collaboration that included women with high risk features who underwent primary surgical staging. RESULTS: One-hundred and seventy-one women were identified (171), 66 in the SLN-A and 105 in the S-LND group, respectively. Pelvic LD was performed on 115 patients (67.2%) and aortic dissection was performed in 54/105 of the women in the S-LND group (51%). The 5-year comparison did not show a significant difference in the strategy adopted for nodal staging, regarding disease-free survival (DFS) [HR: 0.82; 95% CI 0.53-1.28; p = 0.390]. CONCLUSIONS: In this study focusing on women with EC in the HR groups, we did not find a difference in the 5-year DFS when comparing the SLN-A strategy with S-LND. The SLN strategy did not seem to compromise the prognosis of patients with a higher risk of recurrence.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Buda A, Gasparri ML, Puppo A, et al. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy. Gynecol Oncol. 2018. PMID: 29887483. doi:10.1016/j.ygyno.2018.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。